Primary Hyperoxaluria Mutation Genotyping

Mayo Clinic902 enrolled

Overview

This study will help us determine whether certain genetic mutations, more than others, are a cause of more severe disease in Primary Hyperoxaluria.

During your study visit, we will draw one tube, about two teaspoonfuls (1 to 1 ½ teaspoons for children), of blood from your arm to obtain white blood cells. These white blood cells will be used as a source of DNA for genetic testing. We will use the isolated DNA to try to identify the gene that is defective in Primary Hyperoxaluria by comparing it with the structure of genes in normal individuals, patients with Primary Hyperoxaluria, and family members of Primary Hyperoxaluria patients. In family members of primary hyperoxaluria patients, a 24 hour urine test may also be collected.

Study Type

OBSERVATIONAL

Enrollment

902

Conditions

Primary Hyperoxaluria

Interventions

Genetic AnalysisGENETIC

We will draw one tube of blood from your arm to obtain white blood cells. These white blood cells will be used as a source of DNA for genetic testing.

Eligibility

Sex: ALLHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * You have been diagnosed, or you are in the process of being diagnosed Primary Hyperoxaluria * You have a family member diagnosed with Primary Hyperoxaluria

Locations (1)

Mayo Clinic

Rochester, Minnesota, United States

Outcomes

Primary Outcomes

To determine whether certain genetic mutations, more than others, are a cause of more severe disease in Primary Hyperoxaluria

Time frame: 2 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.